EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multi-Omic Approaches in Cancer-Related Micropeptide Identification

Katarina Vrbnjak iD, Raj Nayan Sewduth iD

Proteomes · 13.09.2024 · 12 (3) · 26

DOI: 10.3390/proteomes12030026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Proteomes, online erschienen am 13.09.2024. Verfasst von Katarina Vrbnjak und 1 weiteren Autor:innen. Beteiligte Einrichtung: VIB-KU Leuven Center for Cancer Biology (VIB), 3000 Leuven, Belgium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting tegen Kanker.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the advances in modern cancer therapy, malignant diseases are still a leading cause of morbidity and mortality worldwide. Conventional treatment methods frequently lead to side effects and drug resistance in patients, highlighting the need for novel therapeutic approaches. Recent findings have identified the existence of non-canonical micropeptides, an additional layer of the proteome complexity, also called the microproteome. These small peptides are a promising class of therapeutic agents with the potential to address the limitations of current cancer treatments. The microproteome is encoded by regions of the genome historically annotated as non-coding, and its existence has been revealed thanks to recent advances in proteomic and bioinformatic technology, which dramatically improved the understanding of proteome complexity. Micropeptides have been shown to be biologically active in several cancer types, indicating their therapeutic role. Furthermore, they are characterized by low toxicity and high target specificity, demonstrating their potential for the development of better tolerated drugs. In this review, we survey the current landscape of known micropeptides with a role in cancer progression or treatment, discuss their potential as anticancer agents, and describe the methodological challenges facing the proteome field of research.

Schlagwörter

Stichwörter der Autor:innen

SEPscancermicropeptidesmicroproteome complexitymulti-omicsnon-canonical peptidespeptide drugs

Autor:innen und Institutionen

  • VIB-KU Leuven Center for Cancer Biology (VIB), 3000 Leuven, Belgium.

ORCID-Profile: Katarina Vrbnjak, Raj Nayan Sewduth

Förderung

  • Stichting tegen Kanker

Zitieren

APA

Vrbnjak, K., & Sewduth, R. N. (2024). Multi-Omic Approaches in Cancer-Related Micropeptide Identification. Proteomes, 12(3), 26. https://doi.org/10.3390/proteomes12030026

Vancouver

Vrbnjak K, Sewduth RN. Multi-Omic Approaches in Cancer-Related Micropeptide Identification. Proteomes. 2024;12(3):26. doi:10.3390/proteomes12030026

BibTeX
@article{Vrbnjak2024,
  author = {Vrbnjak, Katarina and Sewduth, Raj Nayan},
  title = {Multi-Omic Approaches in Cancer-Related Micropeptide Identification},
  journal = {Proteomes},
  year = {2024},
  volume = {12},
  number = {3},
  pages = {26},
  doi = {10.3390/proteomes12030026}
}
Kostenlos starten →